BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23703720)

  • 1. Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine.
    Buszman PP; Milewski K; Zurakowski A; Pajak J; Jelonek M; Gasior P; Peppas A; Tellez A; Granada JF; Buszman PE
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):325-33. PubMed ID: 23703720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model.
    Buszman PP; Tellez A; Afari ME; Peppas A; Conditt GB; Rousselle SD; McGregor JC; Stenoien M; Kaluza GL; Granada JF
    JACC Cardiovasc Interv; 2013 Aug; 6(8):883-90. PubMed ID: 23968706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological effect on restenosis and vascular healing of encapsulated paclitaxel nanocrystals delivered via coated balloon technology in the familial hypercholesterolaemic swine model of in-stent restenosis.
    Cheng Y; Shibuya M; McGregor J; Conditt GB; Yi GH; Kaluza GL; Gray W; Doshi M; Sojitra P; Granada JF
    EuroIntervention; 2016 Oct; 12(9):1164-1173. PubMed ID: 27753601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Paclitaxel Dose on Tissue Pharmacokinetics and Vascular Healing: A Comparative Drug-Coated Balloon Study in the Familial Hypercholesterolemic Swine Model of Superficial Femoral In-Stent Restenosis.
    Gongora CA; Shibuya M; Wessler JD; McGregor J; Tellez A; Cheng Y; Conditt GB; Kaluza GL; Granada JF
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1115-1123. PubMed ID: 26117470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model.
    Yazdani SK; Pacheco E; Nakano M; Otsuka F; Naisbitt S; Kolodgie FD; Ladich E; Rousselle S; Virmani R
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):132-40. PubMed ID: 23703778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model.
    Li Y; Tellez A; Rousselle SD; Dillon KN; Garza JA; Barry C; Granada JF
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):89-98. PubMed ID: 26613810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Fluoropolymer-Based Paclitaxel Delivery on Neointimal Proliferation and Vascular Healing: A Comparative Peripheral Drug-Eluting Stent Study in the Familial Hypercholesterolemic Swine Model of Femoral Restenosis.
    Gasior P; Cheng Y; Valencia AF; McGregor J; Conditt GB; Kaluza GL; Granada JF
    Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28487355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of short- and long-term results of drug-eluting vs. bare metal stenting in the porcine internal carotid artery.
    Schwarzmaier-D'Assie A; Nyolczas N; Hemetsberger R; Strehblow C; Matiasek J; Farhan S; Petrasi Z; Huber K; Wojta J; Glogar D; Plass C; Gyöngyösi M; Karnik R
    J Endovasc Ther; 2011 Aug; 18(4):547-58. PubMed ID: 21861747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coating of intravascular balloon with paclitaxel prevents constrictive remodeling of the dilated porcine femoral artery due to inhibition of intimal and media fibrosis.
    Pavo N; Samaha E; Sabdyusheva I; von Strandmann RP; Stahnke S; Plass CA; Zlabinger K; Lukovic D; Jambrik Z; Pavo IJ; Bergler-Klein J; Gray WA; Maurer G; Gyöngyösi M
    J Mater Sci Mater Med; 2016 Aug; 27(8):131. PubMed ID: 27388164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-iopromide coated balloon followed by "bail-out" bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation.
    Milewski K; Tellez A; Aboodi MS; Conditt GB; Yi GH; Thim T; Stenoien M; McGregor JC; Gray WA; Virmani R; Granada JF; Kaluza GL
    EuroIntervention; 2011 Jul; 7(3):362-8. PubMed ID: 21729839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic Drug Effect and Particulate Embolization of Drug-Eluting Stents versus Drug-Coated Balloons in Healthy Swine Femoropopliteal Arteries.
    Torii S; Yahagi K; Mori H; Harari E; Romero ME; Kolodgie FD; Young B; Ragheb A; Virmani R; Finn AV
    J Vasc Interv Radiol; 2018 Jul; 29(7):1041-1049.e3. PubMed ID: 29754850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects on vascular healing of bare metal stents delivered via paclitaxel-coated balloons in the porcine model of restenosis.
    Cremers B; Milewski K; Clever YP; Aboodi MS; Biedermann M; Thim T; Kelsch B; Kaluza GL; Scheller B; Granada JF
    Catheter Cardiovasc Interv; 2012 Oct; 80(4):603-10. PubMed ID: 22511557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of a paclitaxel-incorporated nanoparticle-coated balloon in rabbit and porcine models.
    Yamamoto E; Watanabe S; Bao B; Watanabe H; Nakatsuma K; Izuhara M; Ono K; Nakazawa G; Kimura T; Saito N
    Cardiovasc Revasc Med; 2018 Jun; 19(4):433-437. PubMed ID: 29174499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Analysis of the Paclitaxel-Eluting Peripheral Igaki-Tamai Stent and the Drug-Free Igaki-Tamai Stent Using Optical Coherence Tomography and Histological Analysis in a Porcine Iliac Artery Model.
    Kuwabara K; Zen K; Yashige M; Ito N; Kadoya Y; Wakana N; Yanishi K; Matoba S
    Circ J; 2020 Apr; 84(5):799-805. PubMed ID: 32238644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro particulate and in vivo drug retention study of a novel polyethylene oxide formulation for drug-coated balloons.
    Anderson JA; Lamichhane S; Vierhout T; Sherman A; Engebretson D; Pohlson K; Remund T; Kelly P
    J Vasc Surg; 2018 May; 67(5):1537-1545.e7. PubMed ID: 28843789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of Zilver PTX Drug-Eluting Stent Implantation Following Drug-Coated Balloon Dilation in a Healthy Swine Model.
    Torii S; Yahagi K; Mori H; Harari E; Romero ME; Kolodgie FD; Young B; Ragheb A; Virmani R; Finn AV
    J Endovasc Ther; 2018 Feb; 25(1):118-126. PubMed ID: 29161933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel, vessel anatomy adjusting drug-coated balloon-Preclinical evaluation in peripheral porcine arteries.
    Bienek S; Kusmierczuk M; Mittag A; Bettink S; Scheller B
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):319-328. PubMed ID: 31696642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coating and Pharmacokinetic Evaluation of Air Spray Coated Drug Coated Balloons.
    Turner EA; Atigh MK; Erwin MM; Christians U; Yazdani SK
    Cardiovasc Eng Technol; 2018 Jun; 9(2):240-250. PubMed ID: 29497966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological effect of orbital atherectomy and adjunctive paclitaxel-coated balloon therapy on vascular healing and drug retention: early experimental insights into the familial hypercholesterolaemic swine model of femoral artery stenosis.
    Tellez A; Dattilo R; Mustapha JA; Gongora CA; Hyon CM; Palmieri T; Rousselle S; Kaluza GL; Granada JF
    EuroIntervention; 2014 Dec; 10(8):1002-8. PubMed ID: 25308298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.